841TiP - A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer (mCRPC): CABACARE
| Autor: | Buonerba, C. 1, Bosso, D. 2, De Placido, S. 1, Di Lorenzo, G. 1 |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v292-v293 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|